Paraoxonase-1 genetic polymorphisms and susceptibility to DNA damage in workers occupationally exposed to organophosphate pesticides

Toxicology and Applied Pharmacology

Volumn 252, Issue 2, 2011, Pages 130-137

  Singh, Satyender ^a   Kumar, Vivek ^b   Thakur, Sachin ^a,c   Banerjee, Basu Dev ^b   Rautela, Rajender Singh ^a   Grover, Shyam Sunder ^a   Rawat, Devendra Singh ^a   Pasha, Syed Tazeen ^d   Jain, Sudhir Kumar ^a   Ichhpujani, Rattan Lal ^a,d   Rai, Arvind ^a  

^a National Centre for Disease Control   (India)

^b UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d GOVERNMENT OF INDIA   (India)

Author keywords

Acetylcholinesterase; Arylesterase; DNA damage; Organophosphate pesticides; Paraoxonase; PON1 polymorphism

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ORGANOPHOSPHATE PESTICIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PHENOTYPE;

ADULT; ARYLDIALKYLPHOSPHATASE; CROSS-SECTIONAL STUDIES; DNA DAMAGE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; ORGANOPHOSPHORUS COMPOUNDS; PESTICIDES; POLYMORPHISM, GENETIC;

EID: 79953717389     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.01.014     Document Type: Article

References (56)

1. Bhattacharyya T., Nicholls S.J., Topol E.J., Zhang R., Yang X., Schmitt D., et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 2008, 299(11):1265-1276.
2. Bolognesi C. Genotoxicity of pesticides: a review of human biomonitoring studies. Mutat. Res. 2003, 543:251-272.
3. Bonner M.R., Williams B.A., Rusiecki J.A., Blair A., Beane Freeman L.E., Hoppin J.A., Dosemeci M., Lubin J., Sandler D.P., Alavanja M.C. Occupational exposure to terbufos and the incidence of cancer in the Agricultural Health Study. Cancer Causes Control 2010, 21(6):871-877.
4. Brophy V.H., Jampsa R.L., Clendenning J.B., McKinstry L.A., Jarvik G.P., Furlong C.E. Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am. J. Hum. Genet. 2001, 68:1428-1436.
5. Browne R.O., Moyal-Segal L.B., Zumsteg D., David Y., Kofman O., Berger A., Soreq H., Friedman A. Coding region paraoxonase polymorphisms dictate accentuated neuronal reactions in chronic, sub-threshold pesticide exposure. FASEB J. 2006, 20:1733-1735.
6. Campo S., Sardo M.A., Trimarchi G., Bonaiuto M., Fontana L., Castaldo M., Bonaiuto A., Saitta C., Bitto A., Manduca B., Riggio S., Saitta A. Association between serum paraoxonase (PON1) gene promoter T (-107)C polymorphism, PON1 activity and HDL levels in health Sicilian octogenarians. Exp. Gerontol. 2004, 39:1089-1094.
7. Catano H., Cueva J.L., Cardenas A.M., Izaguirre V., Zavaleta A., Carranza E., Hernandez A.F. Distribution of paraoxonase-1 gene polymorphisms and enzyme activity in a Peruvian population. Environ. Mol. Mutagen. 2006, 47:699-706.
8. Catano H.C., Carranza E., Huamani C., Hernandez A.F. Plasma cholinesterase levels and health symptoms in Peruvian farm workers exposed to organophosphate pesticides. Arch. Environ. Contam. Toxicol. 2008, 55(1):153-159.
9. Chandna S. Single cell gel electrophoresis assay monitors precise kinetics of DNA fragmentation induced during programmed cell death. Cytom. A 2004, 61A:127-133.
10. Chen D., Hu Y., Chen C., Yang F., Fang Z., Wang L., et al. Polymorphisms of the paraoxonase gene and risk of preterm delivery. Epidemiology 2004, 15(4):466-470.
11. Chia S.E., Mohamed A.S., Yap P.H., Gan L., Ong Y.B., Chia K.S. Distribution of PON1 polymorphisms-PON1Q192R and PON1L55M among Chinese, Malay and Indian males in Singapore and possible susceptibility to organophosphate exposure. Neurotoxicology 2009, 30:214-219.
12. Costa L.G., Cole T.B., Vitalone A., Furlong C.E. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Clin. Chim. Acta 2005, 352:37-47.
13. Costa L.G., Vitalone A., Cole T.B., Furlong C.E. Modulation of paraoxonase (PON1) activity. Biochem. Pharmacol. 2005, 69(4):541-550.
14. Da Silva J., Moraes C.R., Heuser V.D., Andrade V.M., Silva F.R., Kvitko K., Emmel V., Rohr P., Bordin D.L., Andreazza A.C., Salvador M., Henriques J.A., Erdtmann B. Evaluation of genetic damage in a Brazilian population occupationally exposed to pesticides and its correlation with polymorphisms in metabolizing genes. Mutagenesis 2008, 23(5):415-422.
15. Davies H., Richter R.J., Kiefer M., Broomfield C., Sowalla J., Furlong C.E. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 1996, 14:334-336.
16. Dich J., Zahm S.H., Hanberg A., Adamai H.O. Pesticides and cancer. Cancer Causes Control 1997, 8:420-443.
17. Eckerson H.W., White C.M., La Du B.N. The human serum paraoxonase/arylesterase polymorphism. Am. J. Hum. Genet. 1983, 35:1126-1138.
18. Erlich P.M., Lunetta K.L., Cupples L.A., Huyck M., Green R.C., Baldwin C.T., et al. Polymorphisms in the PON gene cluster are associated with Alzheimer disease. Hum. Mol. Genet. 2006, 15(1):77-85.
19. Farrow A., Jacobs A., West R.R. Myelodysplasia, chemical exposure and other environmental factors. Leukemia 1989, 3:33-35.
20. Furlong C.E., Cole T.B., Jarvik G.P., Costa L.G. Pharmacogenomic considerations of the paraoxonase polymorphisms. Pharmacogenomics 2002, 3(3):341-348.
21. Furlong C.E., Holland N., Richter R.J., Bradman A., Ho A., Eskenazi B. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharmacogenet. Genomics 2006, 16:183-190.
22. Garin M.C., James R.W., Dussoix P., et al. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme: a possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J. Clin. Invest. 1997, 99:62-66.
23. Geldmacher-von Mallinckrodt M., Diepgen T.L. The human serum paraoxonase - polymorphism and specificity. Toxicol. Environ. Chem. 1988, 18:179-196.
24. Grover P.K., Kanadevi, Mahboob M., Rozati R., Banu B.S., Tahman M.F. Evaluation of genetic damage in workers employed in pesticide production utilizing comet assay. Mutagenesis 2003, 18(2):201-205.
25. Hernandez A.F., Lopez O., Rodrigo L., Gil F., Pena G., Serrano J.L., Parron T., Alvarez J.C., Lorente J.A., Pla A. Changes in erythrocyte enzymes in humans long-term exposed to pesticides: influence of several markers of individual susceptibility. Toxicol. Lett. 2005, 59(1):13-21.
26. Heuser V.D., Erdtmann B., Kvitko K., Rohr P., Da Silva J. Evaluation of genetic damage in Brazilian footwear-workers: biomarkers of exposure, effect, and susceptibility. Toxicology 2007, 232:235-247.
27. Hodgson E., Silver I.S., Butler L.E., Lawton M.P., Levi P.E. Metabolism. Handbook of Pesticides Toxicology 1991, Vol. 1:106-167. Academic Press, San Diego, CA. W.J. Hayes, E.R. Laws (Eds.).
28. Humbert R., Adler D.A., Disteche C.M., Hassett C., Omiecinski C.J., Furlong C.E. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 1993, 3:73-76.
29. Lee E., Oh E., Lee J., Sul D., Lee J. Use of the Tail Moment of the Lymphocytes to Evaluate DNA Damage in Human Biomonitoring Studies. Toxicol. Sci. 2004, 81(1):121-132.
30. Lee C.H., Lee K.Y., Choe K.H., Hong Y.C., Kim Y.D., Kang J.W., Kim H. Effects of oxidative DNA damage induced by polycyclic aromatic hydrocarbons and genetic polymorphism of the paraoxonase-1 (PON1) gene on lung cancer. J. Prev. Med. Public Health 2005, 38(3):345-350.
31. Leviev I., James R.W. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler. Thromb. Vasc. Biol. 2000, 20:516-521.
32. Li W.F., Costa L.G., Richter R.J., Hagen T., Shih D.M., Twadr A., Lusis A.J., Furlong C.E. Catalytic efficiency determines the in vivo efficacy of PON1 in detoxifying organophosphate. Pharmacogenetics 2000, 10:767-780.
33. Liu Y.J., Huang P.L., Chang Y.F., Chen Y.H., Chiou Y.H., Xu Z.L., Wong R.H. GSTP1 genetic polymorphism is associated with a higher risk of DNA damage in pesticide-exposed fruit growers. Cancer Epidemiol. Biomark. Prev. 2006, 15(4):659-666.
34. Lopez-Flores I., Lacasana M., Blanco-Munoz J., Aguilar-Garduno C., Sanchez-Villegas P., Perez-Mendez O.A., Gamboa-Avila R. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides. Toxicol. Lett. 2009, 188:84-90.
35. Mackenzie-Ross S.J., Brewin C.R., Curran H.V., Furlong C.E., Abraham-Smith K.M., Harrison V. Neuropsychological and psychiatric functioning in sheep farmers exposed to low levels of organophosphate pesticides. Neurotoxicol. Teratol. 2010, 32(4):452-459.
36. Mackness M.I., Mackness B., Durrington P.N., Connelly P.W., Hegele R.A. Paraoxonase: biochemistry, genetics and relationships to plasma lipoproteins. Curr. Opin. Lipidol. 1996, 7:69-76.
37. Mansour S.A. Pesticide exposure-Egyptian scene. Toxicology 2004, 198(1-3):91-115.
38. Perez-Herrera N., Polanco-Minaya H., Salazar-Arredondo E., Solis-Heredia M.J., Hernandez-Ochoa I., Rojas-Garcia E., et al. PON1Q192R genetic polymorphism modifies organophosphorous pesticide effects on semen quality and DNA integrity in agricultural workers from southern Mexico. Toxicol. Appl. Pharmacol. 2008, 230(2):261-268.
39. Playfer J.R., Eze L.C., Bullen M.F., Evans D.A. Genetic polymorphism and interethnic variability of plasma paroxonase activity. J. Med. Genet. 1976, 13:337-342.
40. Potti A., Panwalkar A.W., Langness E. Prevalence of pesticide exposure in young males (
41. Rao M.N., Marmillot P., Gong M., Palmer D.A., Seeff L.B., Strader D.B., Lakshman M.R. Light, but not heavy alcohol drinking, stimulates paraoxonase by up regulating liver mRNA in rats and humans. Metabolisms 2003, 52:1287-1294.
42. Richter R.J., Furlong C.E. Determination of paraoxonase (PON1) status requires more than genotyping. Phamacogenetics 1999, 9:745-753.
43. Rohr P., Da Silva J., Erdtmann B., Saffi J., Guecheva T.N., Henriques J.A., Kvitko K. BER gene polymorphisms (OGG1 Ser326Cys and XRCC1 Arg194Trp) and modulation of DNA damage due to pesticides exposure. Environ. Mol. Mutagen. 2011, 52:20-27.
44. Rojas-Garcia A.E., Solis-Heredia M.J., Pina-Guzman B., Vega L., Lopez-Carrillo L., Quintanilla-Vega B. Genetic polymorphisms and activity of PON1 in a Mexican population. Toxicol. Appl. Pharmacol. 2005, 205:282-289.
45. Rojas-Garcia A.E., Sordo M., Vega L., Quintanilla-Vega B., Solis-Heredia M., Ostrosky-Wegman P. The role of paraoxonase polymorphisms in the induction of micronucleus in paraoxon-treated human lymphocytes. Environ. Mol. Mutagen. 2009, 50(9):823-829.
46. Sepahvand F., Rahimi-Moghaddam P., Shafiei M., Ghaffari S.M., Rostam-Shirazi M., Mahmoudian M. Frequency of paraoxonase 192/55 polymorphism in an Iranian population. J. Toxicol. Environ. Health A 2007, 70:1125-1129.
47. Seres I., Bajnok L., Harangi M., Sztanek F., Koncsos P., Paragh G. Alteration of PON1 activity in adult and childhood obesity and its relation to adipokine levels. Adv. Exp. Med. Biol. 2010, 660:129-142.
48. Seth V., Banerjee B.D., Bhattacharya A., Pasha S.T., Chakravarty A.K. Pesticide induced alterations in acetylcholine esterase and gamma glutamyl ptarspeptidase activities and glutathione level in lymphocytes of human poisoning cases. Clin. Biochem. 2001, 34:427-429.
49. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
50. Sirivarasai J., Kaojarern S., Yoovathaworn K., Sura T. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects. Chem. Biol. Interact. 2007, 68(3):184-192.
51. Suheiro T., Nakamura T., Inoue M., Shiinoki T., Ikeda Y., Kumon Y., Shindo M., Tanaka H., Hashimoto K. A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression. Atherosclerosis 2000, 150:295-298.
52. Thyagarajan B., Jacobs D.R., Carr J.J., Alozie O., Steffes M.W., Kailash P., Hayes J.H., Gross M.D. Factors associated with paraoxonase genotypes and activity in a diverse, young, healthy population: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Clin. Chem. 2008, 54(4):738-746.
53. Waddell B.L., Zahm S.H., Baris D., Weisenburger D.D., Holmes F., Burmeister L.F., Cantor K.P., Blair A. Agricultural use of organophosphate pesticides and the risk of non-Hodgkin's lymphoma among male farmers (United States). Cancer Causes Control 2001, 12(6):509-517.
54. Wang X., Huang J., Fan Z., Su S., Zhao J., Shen Y., Qiang B., Gu D. Genetic and environmental factors associated with plasma paraoxonase activity in healthy Chinese. Int. J. Mol. Med. 2004, 13:445-450.
55. Wong R.H., Chang S.Y., Ho S.W., Huang P.L., Liu Y.J., Chen Y.C., Yeh Y.H., Lee H.S. Polymorphisms in metabolic GSTP1 and DNA-repair XRCC1 genes with an increased risk of DNA damage in pesticide-exposed fruit growers. Mutat. Res. 2008, 654(2):68-75.
56. Zintzaras E., Hadjigeorgiou G.M. Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis. J. Hum. Genet. 2004, 49(9):474-481.